These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 12200518)

  • 21. Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD.
    Staples KJ; Taylor S; Thomas S; Leung S; Cox K; Pascal TG; Ostridge K; Welch L; Tuck AC; Clarke SC; Gorringe A; Wilkinson TM
    PLoS One; 2016; 11(11):e0167250. PubMed ID: 27898728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory Pathogens at Exacerbation in Chronic Bronchitis With Airway Bacterial Colonisation: A Cohort Study.
    Jones TL; Roberts C; Elliott S; Glaysher S; Green B; Shute JK; Chauhan AJ
    Clin Respir J; 2024 Aug; 18(8):e13811. PubMed ID: 39162176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
    Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
    Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa.
    Millares L; Ferrari R; Gallego M; Garcia-Nuñez M; Pérez-Brocal V; Espasa M; Pomares X; Monton C; Moya A; Monsó E
    Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1101-11. PubMed ID: 24449346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human rhinovirus infection during naturally occurring COPD exacerbations.
    George SN; Garcha DS; Mackay AJ; Patel AR; Singh R; Sapsford RJ; Donaldson GC; Wedzicha JA
    Eur Respir J; 2014 Jul; 44(1):87-96. PubMed ID: 24627537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbes responsible for acute exacerbation of COPD.
    Bari MR; Hiron MM; Zaman SM; Rahman MM; Ganguly KC
    Mymensingh Med J; 2010 Oct; 19(4):576-85. PubMed ID: 20956903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD.
    Singh R; Belchamber KBR; Fenwick PS; Chana K; Donaldson G; Wedzicha JA; Barnes PJ; Donnelly LE;
    Respir Res; 2021 Apr; 22(1):113. PubMed ID: 33879129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD.
    Wilkinson TMA; Aris E; Bourne S; Clarke SC; Peeters M; Pascal TG; Schoonbroodt S; Tuck AC; Kim V; Ostridge K; Staples KJ; Williams N; Williams A; Wootton S; Devaster JM;
    Thorax; 2017 Oct; 72(10):919-927. PubMed ID: 28432209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
    Bhowmik A; Seemungal TA; Sapsford RJ; Wedzicha JA
    Thorax; 2000 Feb; 55(2):114-20. PubMed ID: 10639527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species.
    Simpson JL; Baines KJ; Horvat JC; Essilfie AT; Brown AC; Tooze M; McDonald VM; Gibson PG; Hansbro PM
    Respirology; 2016 May; 21(4):697-704. PubMed ID: 26781464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
    Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
    Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.
    Roland M; Bhowmik A; Sapsford RJ; Seemungal TA; Jeffries DJ; Warner TD; Wedzicha JA
    Thorax; 2001 Jan; 56(1):30-5. PubMed ID: 11120901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.
    Patel IS; Vlahos I; Wilkinson TM; Lloyd-Owen SJ; Donaldson GC; Wilks M; Reznek RH; Wedzicha JA
    Am J Respir Crit Care Med; 2004 Aug; 170(4):400-7. PubMed ID: 15130905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
    Venning V; Bartlett J; Jayaram L
    Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.
    Seemungal TA; Harper-Owen R; Bhowmik A; Jeffries DJ; Wedzicha JA
    Eur Respir J; 2000 Oct; 16(4):677-83. PubMed ID: 11106212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial exacerbations of chronic obstructive pulmonary disease. The role of lung function in aetiology of exacerbation.
    Kieszko R; Szmygin-Milanowska K; Chudnicka A; Gołebiowska I; Łagozna J; Milanowski J
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):475-80. PubMed ID: 15315034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Airway Bacteria Quantification Using Polymerase Chain Reaction Combined with Neutrophil and Eosinophil Counts Identifies Distinct COPD Endotypes.
    Beech A; Lea S; Li J; Jackson N; Mulvanny A; Singh D
    Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.
    Miravitlles M; Espinosa C; Fernández-Laso E; Martos JA; Maldonado JA; Gallego M
    Chest; 1999 Jul; 116(1):40-6. PubMed ID: 10424501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.